Merck's latest Form 10-K reports Gardasil/Gardasil 9 revenue of $5,233 million in 2025, down 39% from $8,583 million in 2024 and $8,886 million in 2023.
Gardasil/Gardasil 9 5,233
Merck FY2025 Form 10-K, product-revenue table
Merck's latest Form 10-K reports Gardasil/Gardasil 9 revenue of $5,233 million in 2025, down 39% from $8,583 million in 2024 and $8,886 million in 2023. Exceeds the book's '$4 billion' figure for the latest year but is falling sharply on China demand.